MRKR logo

Marker Therapeutics, Inc.

MRKR
Healthcare|Biotechnology|US
$0.89
-0.00 (-0.30%)
DCF Value
$1.08
Tangible Book / Share
$0.63
Cash / Share
$0.59

Ownership Breakdown

81.0%
Float
16.7M
Shares Outstanding
13.5M
Float Shares

Major Holders (15)

Combined: 143.8%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Blue Owl Capital Holdings LPPartnership9.99%1,127,052May 15, 202513D/G
Ali BehbahaniIndividual9.90%1,670,081Nov 17, 202513D/G
Carmen ChangIndividual9.90%1,670,081Nov 17, 202513D/G
NEA Partners 16, L.P.Partnership9.90%1,670,081Nov 17, 202513D/G
Scott D. SandellIndividual9.90%1,670,081Nov 17, 202513D/G
Paul WalkerIndividual9.90%1,670,081Nov 17, 202513D/G
Anthony A. Florence, Jr.Individual9.90%1,670,081Nov 17, 202513D/G
Mohamad H. MakhzoumiIndividual9.90%1,670,081Nov 17, 202513D/G
New Enterprise Associates 16, L.P.Partnership9.90%1,670,081Nov 17, 202513D/G
Nea 16 GP, LLCOther9.90%1,670,081Nov 17, 202513D/G
Forest BaskettIndividual9.90%1,670,081Nov 17, 202513D/G
Anand ParekhIndividual9.90%1,280,952Nov 14, 202513D/G
Alyeska Investment Group, L.P.Investment adviser9.90%1,280,952Nov 14, 202513D/G
Alyeska Fund GP, LLCOther9.90%1,280,952Nov 14, 202513D/G
John R. Wilson TTE, John R. Wilson Revocable Trust U/A DTD 08/03/2017Individual5.10%659,901Aug 19, 202513D/G

Insider Trades (100)

Last 4 quarters: 1,900,169 acquired · 0 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Knobil KatharinedirectorNov 17, 2025AWARD137,330$0.95$131.1KForm 4
Knobil KatharinedirectorNov 17, 2025AWARD84,411$0.95$80.6KForm 4
Eansor Norman DaviddirectorNov 17, 2025AWARD137,330$0.95$131.1KForm 4
Eansor Norman DaviddirectorNov 17, 2025AWARD84,411$0.95$80.6KForm 4
ELMS STEVEdirectorNov 17, 2025AWARD137,330$0.95$131.1KForm 4
ELMS STEVEdirectorNov 17, 2025AWARD84,411$0.95$80.6KForm 4
Corzo Kathryn PenkusdirectorOct 31, 2025AWARD147,611$0.99$145.8KForm 4
Vera Juandirector, officer: Chief Executive OfficerOct 31, 2025AWARD250,000$0.99$246.9KForm 4
Corzo Kathryn Penkusdirector: Oct 31, 2025OTHER0——Form 4
ELMS STEVEdirectorFeb 12, 2025AWARD30,000$1.59$47.7KForm 4
Knobil KatharinedirectorFeb 12, 2025AWARD30,000$1.59$47.7KForm 4
Eansor Norman DaviddirectorFeb 12, 2025AWARD30,000$1.59$47.7KForm 4
Vera Juandirector, officer: President and CEOFeb 12, 2025AWARD50,000$1.59$79.5KForm 4
ELMS STEVEdirectorDec 23, 2024BUY11,085$3.20$35.5KForm 4
New Enterprise Associates 16, L.P.10 percent ownerDec 23, 2024BUY554,250$3.20$1.8MForm 4
Lurier Eliot MofficerJun 30, 2023OTHER0——Form 4
Eansor Norman DaviddirectorMar 16, 2021BUY14,285$17.50$250.0KForm 4
Eansor Norman DaviddirectorJun 6, 2023AWARD8,000$1.72$13.8KForm 4
Eansor Norman DaviddirectorMar 25, 2021GIFT7,142——Form 4
Eansor Norman DaviddirectorMar 25, 2021GIFT14,285——Form 4
Knobil KatharinedirectorJun 6, 2023AWARD8,000$1.72$13.8KForm 4
Wilson John RobertdirectorJun 6, 2023AWARD8,000$1.72$13.8KForm 4
ELMS STEVEdirectorJun 6, 2023AWARD8,000$1.72$13.8KForm 4
Vera Juandirector, officer: President and CEOMay 10, 2023AWARD100,000$1.42$142.0KForm 4
Hoang Tsvetelina PVP, Research and DevelopmentFeb 27, 2023AWARD33,159$2.14$71.0KForm 4
Koneru MythiliChief Medical OfficerFeb 27, 2023AWARD51,918$2.14$111.1KForm 4
Loiacono MichaelChief Accounting OfficerFeb 27, 2023AWARD38,480$2.14$82.3KForm 4
Vera Juandirector, officer: Chief Scientific Officer & COOFeb 27, 2023AWARD46,487$2.14$99.5KForm 4
Szymanska AnnaVice President, QualityFeb 27, 2023AWARD29,947$2.14$64.1KForm 4
Agopyan NadiaSVP, Regulatory AffairsFeb 27, 2023AWARD34,154$2.14$73.1KForm 4
Wilson John Robertdirector: May 24, 2022AWARD80,000——Form 4
Laskow-Pooley Daviddirector: May 24, 2022AWARD80,000——Form 4
Knobil KatharinedirectorMay 24, 2022AWARD80,000$0.34$27.0KForm 4
Knobil Katharinedirector: May 24, 2022AWARD80,000——Form 4
ELMS STEVEdirector: May 24, 2022AWARD80,000——Form 4
ELMS STEVEdirectorMay 24, 2022AWARD80,000$0.34$27.0KForm 4
Eansor Norman Daviddirector: May 24, 2022AWARD80,000——Form 4
Eansor Norman DaviddirectorMay 24, 2022AWARD80,000$0.34$27.0KForm 4
Hoang Peter L.President and CEOMar 24, 2022AWARD199,094——Form 4
Hoang Peter L.President and CEOMar 24, 2022TAX W/H48,376$0.48$23.5KForm 4
Vera JuanChief Scientific Officer & COOMar 24, 2022AWARD140,823——Form 4
Vera JuanChief Scientific Officer & COOMar 24, 2022TAX W/H33,465$0.48$16.2KForm 4
Kim Anthony H.Chief Financial OfficerMar 24, 2022AWARD150,512——Form 4
Kim Anthony H.Chief Financial OfficerMar 24, 2022TAX W/H36,076$0.48$17.5KForm 4
Hoang Peter L.director, officer: President and CEOFeb 17, 2022AWARD430,000$0.46$197.8KForm 4
Vera Juandirector, officer: Chief Scientific Officer & COOFeb 17, 2022AWARD160,000$0.46$73.6KForm 4
Szymanska AnnaVice President, QualityFeb 17, 2022AWARD40,000$0.46$18.4KForm 4
Loiacono MichaelChief Accounting OfficerFeb 17, 2022AWARD140,000$0.46$64.4KForm 4
Koneru MythiliChief Medical OfficerFeb 17, 2022AWARD160,000$0.46$73.6KForm 4
Kim Anthony H.Chief Financial OfficerFeb 17, 2022AWARD160,000$0.46$73.6KForm 4
Hoang Tsvetelina PVP, Research and DevelopmentFeb 17, 2022AWARD40,000$0.46$18.4KForm 4
Garrett GeraldVice President, Clinical Ops.Feb 17, 2022AWARD40,000$0.46$18.4KForm 4
Agopyan NadiaVP, Regulatory AffairsFeb 17, 2022AWARD40,000$0.46$18.4KForm 4
Knobil KatharinedirectorDec 8, 2021AWARD125,000$1.20$150.0KForm 4
Knobil KatharinedirectorDec 8, 2021OTHER0——Form 4
Wasserman Frederick GeralddirectorJun 8, 2021AWARD12,658——Form 4
Laskow-Pooley DaviddirectorJun 8, 2021AWARD12,658——Form 4
ELMS STEVEdirectorJun 8, 2021AWARD12,658——Form 4
Eansor Norman DaviddirectorJun 8, 2021AWARD12,658——Form 4
Wilson John RobertdirectorJun 8, 2021AWARD12,658——Form 4
Wasserman Frederick GeralddirectorMay 18, 2021BUY10,000$2.41$24.1KForm 4
Walker Paul Edward10 percent ownerMar 16, 2021BUY5,714,285$1.75$10.0MForm 4
Sonsini Peter W.10 percent ownerMar 16, 2021BUY5,714,285$1.75$10.0MForm 4
SANDELL SCOTT D10 percent ownerMar 16, 2021BUY5,714,285$1.75$10.0MForm 4
MAKOWER JOSHUA10 percent ownerMar 16, 2021BUY5,714,285$1.75$10.0MForm 4
Makhzoumi Mohamad10 percent ownerMar 16, 2021BUY5,714,285$1.75$10.0MForm 4
Florence Anthony A. Jr.10 percent ownerMar 16, 2021BUY5,714,285$1.75$10.0MForm 4
Chang Carmen10 percent ownerMar 16, 2021BUY5,714,285$1.75$10.0MForm 4
Behbahani Ali10 percent ownerMar 16, 2021BUY5,714,285$1.75$10.0MForm 4
BASKETT FOREST10 percent ownerMar 16, 2021BUY5,714,285$1.75$10.0MForm 4
New Enterprise Associates 16, L.P.10 percent ownerMar 16, 2021BUY5,714,285$1.75$10.0MForm 4
Wilson John RobertdirectorMar 16, 2021BUY1,714,285$1.75$3.0MForm 4
Vera JuanChief Development OfficerMar 16, 2021BUY571,428$1.75$1000.0KForm 4
Hoang Peter L.director, officer: President and CEOMar 16, 2021BUY142,857$1.75$250.0KForm 4
ELMS STEVEdirectorMar 16, 2021BUY1,142,857$1.75$2.0MForm 4
Leen Ann M.officerFeb 15, 2020OTHER0——Form 4
Vera JuanChief Development OfficerFeb 10, 2021AWARD140,000$3.29$460.6KForm 4
Szymanska AnnaVice President, QualityFeb 10, 2021AWARD40,000$3.29$131.6KForm 4
Loiacono MichaelChief Accounting OfficerFeb 10, 2021AWARD140,000$3.29$460.6KForm 4
Koneru MythiliChief Medical OfficerFeb 10, 2021AWARD140,000$3.29$460.6KForm 4
Kim Anthony H.Chief Financial OfficerFeb 10, 2021AWARD160,000$3.29$526.4KForm 4
Hoang Tsvetelina PVP, Research and DevelopmentFeb 10, 2021AWARD40,000$3.29$131.6KForm 4
Hoang Peter L.director, officer: President and CEOFeb 11, 2021AWARD430,000$3.06$1.3MForm 4
Garrett GeraldVice President, Clinical Ops.Feb 10, 2021AWARD40,000$3.29$131.6KForm 4
Agopyan NadiaVP, Regulatory AffairsFeb 10, 2021AWARD40,000$3.29$131.6KForm 4
Wilson John RobertdirectorMay 19, 2020AWARD17,022——Form 4
Wilson John Robertdirector: Dec 31, 2020OTHER0——Form 4
Wasserman Frederick GeralddirectorMay 19, 2020AWARD17,022——Form 4
Wasserman Frederick Geralddirector: Dec 31, 2020OTHER0——Form 4
Laskow-Pooley DaviddirectorMay 19, 2020AWARD17,022——Form 4
Laskow-Pooley Daviddirector: Dec 31, 2020OTHER0——Form 4
ELMS STEVEdirectorDec 31, 2020OTHER0——Form 4
ELMS STEVEdirectorDec 31, 2020OTHER0——Form 4
ELMS STEVEdirectorMay 19, 2020AWARD17,022——Form 4
Eansor Norman DaviddirectorMay 19, 2020AWARD17,022——Form 4
Eansor Norman Daviddirector: Dec 31, 2020OTHER0——Form 4
Eastern Capital LTD10 percent owner: Nov 9, 2020OTHER0——Form 4
Eastern Capital LTD10 percent ownerJun 16, 2020DISPOSED416,667$15.00$6.3MForm 4
Hoang Peter L.director, officer: President and CEOMar 10, 2020AWARD388,800$2.12$824.3KForm 4
Hoang Peter L.director, officer: President and CEOMar 10, 2020AWARD41,200$2.12$87.3KForm 4